Kabeer Aziz - Jun 7, 2023 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
Director, 10%+ Owner
Signature
/s/ Joshua Eizen, Attorney-in-Fact for Kabeer Aziz
Stock symbol
ANTX
Transactions as of
Jun 7, 2023
Transactions value $
$0
Form type
4
Date filed
6/9/2023, 09:04 PM
Previous filing
Jun 24, 2022
Next filing
Sep 15, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANTX Stock Option (right to buy) Award $0 +23.7K $0.00 23.7K Jun 7, 2023 Common Stock 23.7K $5.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shares shall vest on the earlier of (a) the one-year anniversary of June 7, 2023 or (b) the day prior to the date of the Issuer's next annual stockholder meeting, subject to the Reporting Person providing continuous service through such vesting date.